Full-Time

Clinical Pharmacist

Updated on 9/4/2026

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$102.2k - $170.4k/yr

Ashland, VA, USA

In Person

Travel up to 5% within the state is required.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Quality Assurance (QA)
Excel/Numbers/Sheets

Get referred to Option Care Health

See people who can refer or advise you

Requirements
  • The candidate must be a graduate of an accredited School of Pharmacy.
  • The candidate must hold a current, active pharmacy license granted by the State Board of Pharmacy.
  • The candidate must have at least one year of experience in sterile intravenous admixture procedures, knowledge of non-sterile compounding, immunizations and medication therapy management, completion of an American Society of Health-System Pharmacists-accredited Pharmacy Residency Program, completion of an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy, or equivalent experience approved by pharmacy leadership.
  • The candidate must have experience providing customer service to internal and external customers, including meeting service quality standards and evaluating customer satisfaction.
  • The candidate must have basic-level proficiency in Microsoft Word.
  • The candidate must have basic-level proficiency in Microsoft Excel.
  • The candidate must have basic-level proficiency in Microsoft PowerPoint.
  • The candidate must be willing to travel up to 5% of the time for business purposes within the state.
Responsibilities
  • Determine the suitability of individual patients for home care by collecting and organizing patient-specific information and assessing medical condition, prescribed medication therapy, prognosis and outcome goals.
  • Design, recommend, monitor and evaluate patient-specific pharmacy care plans for home-care pharmacotherapy, including recommendations for medication-therapy or monitoring-parameter modifications when appropriate.
  • Modify pharmacy care plans based on monitoring data and other pertinent patient-specific information, using pharmacokinetic principles and formulas and assessing patient laboratory values.
  • Provide medication-use education and counseling to staff, healthcare professionals, patients and caregivers.
  • Ensure continuity of pharmaceutical care between the home and other patient-care settings by systematically communicating pertinent patient information.
  • Prepare and dispense medications using appropriate techniques and organizational procedures; calibrate equipment; ensure appropriate concentration, compatibility, stability, storage, labeling, final inspection and authorization to dispense.
  • Comply with state and federal laws, United States Pharmacopeia standards, Drug Enforcement Administration controlled-substance regulations and perpetual inventory policies for controlled substances and medications subject to diversion.
  • Manage, maintain, troubleshoot, program and provide guidance on medication-administration and medication-related equipment.
  • Assess, manage and report medication-related incidents and equipment errors or failures, and complete quality assurance reporting documents.
  • Monitor and report discrepancies in perpetual inventory systems for controlled substances and other medications subject to diversion.
  • Respond to drug-information requests from healthcare providers and home-care patients based on analysis of the literature.
  • Attend educational seminars or participate in continuing education opportunities to maintain professional competency and satisfy state continuing-education requirements.
  • Manage investigational drug products according to established regulations and organizational policies and procedures.
  • Effectively utilize pharmacy support personnel, prioritize workload and organize workflow according to available resources.
  • Ensure the accuracy of pharmacy support personnel's work.
  • Comply with accreditation, legal, regulatory and safety requirements.
  • Maintain confidentiality of patient and proprietary information and observe legal and ethical confidentiality guidelines.
Desired Qualifications
  • Completion of an American Society of Health-System Pharmacists-accredited Pharmacy Residency Program or an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy.
  • Experience in home care, hospital or another clean-room setting.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.

Yahoo Finance
Jun 9th, 2026
Goldman Sachs initiates Option Care Health coverage with neutral rating, $22 price target

Option Care Health shares rose 3.5% after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, suggesting potential upside from the stock's recent price of $20.51. The move comes after the stock declined 33% over the previous six months. Whilst Goldman Sachs took a cautious stance, other firms including Deutsche Bank and UBS maintain Buy ratings on the stock. The company recently reported weak first-quarter 2026 results, with revenue of $1.35 billion missing forecasts despite a 1.3% year-on-year increase. Option Care Health also lowered its full-year revenue guidance to $5.73 billion, below analyst estimates. The stock is down 35.5% year-to-date and trading 43.2% below its 52-week high.

Associated Press
Jun 4th, 2026
Option Care Health appoints Robert Okunski as VP of investor relations

Option Care Health has appointed Robert Okunski as Vice President of Investor Relations, effective 26 May 2026. He will lead the company's investor relations strategy and serve as primary liaison with the investment community. Okunski brings over 20 years of investor relations experience across healthcare, technology and energy sectors. He joins from Enhabit Home Health & Hospice, where he served as Vice President of Investor Relations, and previously held senior positions at Velo3D, SunPower Corporation, Spansion and PeopleSoft. Option Care Health is the largest independent provider of home and alternate site infusion services in the US, employing over 8,000 staff including more than 5,000 clinicians across all 50 states.

Yahoo Finance
May 28th, 2026
Option Care Health posts weakest Q1 among home health stocks, shares drop 27%

Option Care Health, the largest independent provider of home infusion services in the US, reported Q1 revenues of $1.35 billion, up 1.3% year on year but missing analyst expectations by 3.3%. The company operates 177 locations across 43 states with over 4,500 clinicians. Chief executive John Rademacher acknowledged the "mixed performance" and expressed dissatisfaction with revenue growth momentum. Full-year guidance also fell short of analyst expectations. Across the senior health, home health and hospice sector, seven tracked companies reported a satisfactory Q1, with revenues beating consensus estimates by 0.9% on average. However, Option Care Health posted the weakest performance against analyst estimates despite raising full-year guidance. The stock has fallen 27.1% since reporting, currently trading at $21.59.